UAE Adopts Abridged Reviews For Faster Drug Approvals
The United Arab Emirates has published a new decree setting out procedures for accelerated reviews of innovative and orphan medicines, creating a new standard for the rest of the gulf region.
You may also be interested in...
The UAE, Jordan, Egypt and Saudi Arabia have all recently announced or implemented new verification/abridged regulatory pathways to improve access to medicines and free up resources.
Insurers argue that better use of real world data and multiple pricing assessments could help lower drug prices in Germany.
To keep investors happy, companies will have to start showing that their high-priced advanced therapies offset costs elsewhere in the health care system.